BN Business News
Add your company to Business Communicator →

Business · 01/10/2012

FDA Releases Guidance on Developing Antimicrobial Drugs for COPD Patients

The FDA has released a guidance for industry on developing antimicrobial drugs to treat acute bacterial exacerbations of chronic bronchitis in patients with chronic obstructive pulmonary disease (COPD).

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights